Contrast-enhanced mammography versus conventional imaging in women recalled from breast cancer screening (RACER trial): a multicentre, open-label, randomised controlled clinical trial
-
Published:2024-09
Issue:
Volume:44
Page:100987
-
ISSN:2666-7762
-
Container-title:The Lancet Regional Health - Europe
-
language:en
-
Short-container-title:The Lancet Regional Health - Europe
Author:
Neeter Lidewij M.F.H.ORCID,
Nelemans Patricia J.,
Raat H.P.J.,
Frotscher Caroline,
Duvivier Katya M.,
Essers Brigitte A.B.,
Smidt Marjolein L.,
Wildberger Joachim E.,
Lobbes Marc B.I.ORCID
Reference30 articles.
1. Breast cancer screening halves the risk of breast cancer death: a case-referent study;Paap;Breast,2014
2. Uitvoeringskader bevolkingsonderzoek borstkanker;Rijksinstituut voor Volksgezondheid en Milieu (RIVM),2023
3. Bevolkingsonderzoek borstkanker - factsheet;Rijksinstituut voor Volksgezondheid en Milieu (RIVM),2021
4. Cost of breast-related care in the year following false positive screening mammograms;Chubak;Med Care,2010
5. Psychological consequences of false-positive screening mammograms in the UK;Bond;BMJ Evid Based Med,2013